Clinical trial / 2017
Wolfberry extract intake for 8 weeks reduced lymphocyte DNA damage and altered antioxidant enzyme activity and mRNA expression in overweight subjects.
In a double-blind trial, 53 overweight and mild hypercholesterolemic subjects consumed an 80 mL pouch containing 13.5 g of wolfberry extract (WBE) or placebo daily after a meal for 8 weeks. WBE supplementation resulted in a slight but significant decrease in erythrocyte superoxide dismutase activity and an increase in catalase activity. Endogenous DNA damage in lymphocytes, evaluated as the percentage of DNA in the tail via alkaline comet assay, significantly decreased with 8 weeks of WBE. In addition, the proportion of significantly deregulated mRNAs related to oxidative or inflammatory stress was considerably higher in the WBE group.
- Study type
- Double-blind, randomized, placebo-controlled parallel trial
- Who was studied
- 53 mild hypercholesterolemic and overweight subjects
- What was measured
- Erythrocyte antioxidant enzyme activity, lymphocyte endogenous DNA damage, and oxidative or inflammatory mRNA expression
THE PAPER
Dietary Wolfberry Extract Modifies Oxidative Stress by Controlling the Expression of Inflammatory mRNAs in Overweight and Hypercholesterolemic Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial.
Lee YJ, Ahn Y, Kwon O, Lee MY, Lee CH, Lee S, Park T, Kwon SW, Kim JY. J Agric Food Chem, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.